Patent ID: 9737616
Date: 2017-08-22
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method of treating HER2 expressing breast cancer or HER2 expressing gastric cancer in a patient in need thereof comprising administering an effective amount of a compound of Formula 1a: or a salt thereof, wherein X is hydrogen or halo; Y is selected from the group consisting of hydrogen, C R R R R R R R R n is 0, 1, 2, 3, 4, 5, 6, 7 or 8; p is selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; and Anti-HER2 is an anti-ERB B2/NEU (HER2) antibody.